Join the Oncology Voice Network. Join for Free
The Path from Clinical Practice to Field Medical (MSL, CSL or CPL)
Clinical Practice Liaison Field Medical Positions Medical Science Liaisons Transition to Industry Emotional Intelligence in Healthcare

The Path from Clinical Practice to Field Medical (MSL, CSL or CPL)


Share This Article


Summary

In this episode, Jessica Johnson and Whitney Theiss from Neurocrine Biosciences join Tom Caravela to explore the transition from clinical roles to field medical positions, focusing on the Clinical Practice Liaison (CPL) role. They discuss the responsibilities and skills required for CPLs, comparing them to those of Medical Science Liaisons (MSLs). The episode delves into the challenges CPLs face, performance evaluation, and career progression, including the impact of remote work trends. Jessica and Whitney offer valuable advice for clinicians considering a transition, emphasizing the significance of emotional intelligence. The episode wraps up with key takeaways and closing thoughts.

My guests today are Jessica Johnson Director, Clinical Practice Liaisons and Whitney Tice, Clinical Practice Liaison at Neurocrine and we discuss the path from clinical practice to Field Medical.

In this episode we discuss:

  • Jessica and Whitney’s background
  • The transition from clinician into industry
  • Why are clinicians good candidates for Field Medical positions
  • What is a clinical practice liaison, responsibilities and difference from an MSL
  • What are the skill sets they look for in a CPL when hiring
  • What types of training is required for CPLs and the implemented in the organization
  • What makes a top-performing CPL
  • What can people aspire from the CPL role
  • Advice for a clinician trying to get into the role and how they can be successful

Click for Source
Clinical Practice Liaison, Field Medical Positions, Medical Science Liaisons, Transition to Industry, Emotional Intelligence in Healthcare

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Explore OVN